CME Group Inc (NASDAQ: CME) open the trading on Thursday, with great promise as it jumped 0.83% to $281.39, before settling in for the price of $279.07 at the close. Taking a more long-term approach, CME posted a 52-week range of $230.80-$290.79.
The Financial sector firm’s twelve-monthly sales growth has been 10.36% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 10.36%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 8.96%. This publicly-traded company’s shares outstanding now amounts to $359.85 million, simultaneously with a float of $356.85 million. The organization now has a market capitalization sitting at $101.47 billion.
CME Group Inc (CME) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Financial Data & Stock Exchanges industry. CME Group Inc’s current insider ownership accounts for 0.42%, in contrast to 91.45% institutional ownership. According to the most recent insider trade that took place on Dec 30 ’25, this organization’s Director bought 251 shares at the rate of 278.37, making the entire transaction reach 69,929 in total value, affecting insider ownership by 258,710. Preceding that transaction, on Dec 30 ’25, Company’s Director bought 11 for 278.37, making the whole transaction’s value amount to 3,079. This particular insider is now the holder of 2,477 in total.
CME Group Inc (CME) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.95 per share during the current fiscal year.
CME Group Inc’s EPS increase for this current 12-month fiscal period is 8.96% and is forecasted to reach 11.71 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 6.57% through the next 5 years, which can be compared against the 10.36% growth it accomplished over the previous five years trading on the market.
CME Group Inc (NASDAQ: CME) Trading Performance Indicators
Let’s observe the current performance indicators for CME Group Inc (CME). It’s Quick Ratio in the last reported quarter now stands at 1.02. Alongside those numbers, its PE Ratio stands at $27.28, and its Beta score is 0.28. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 15.86. Similarly, its price to free cash flow for trailing twelve months is now 24.85.
In the same vein, CME’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 10.32, a figure that is expected to reach 2.75 in the next quarter, and analysts are predicting that it will be 11.71 at the market close of one year from today.
